Efficacy and Safety of AJU-C52 in Essential Hypertension Patients

Clinical trial NCT06416865 · UNKNOWN

Trial details

NCT number: NCT06416865
Sponsor: AJU Pharm Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2022-06-27
Primary completion: 2022-12-12
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.